China Internet Stock Gains Face Reality Check in Nvidia Fallout

Democrats Open Probe Into Trump’s Deal to Export Nvidia Chips to China notus.org

China eyes South China Sea control for Taiwan invasion: Japan think tank Japan Wire by Kyodo News

China has approved US pharmaceutical giant Eli Lilly’s weight-loss pill orforglipron, making it the country’s first available oral GLP-1 treatment for obesity as global drug makers seek to tap the country’s massive weight-management market. China’s National Medical Products Administration announced the approval on Thursday, saying that the once-daily pill, marketed as Foundayo, could be used for chronic weight management by obese or overweight adults. GLP-1 receptor agonists are synthetic...

No more needles: Eli Lilly wins China nod for first oral GLP-1 weight-loss drug South China Morning Post